Interventional Cardiology & Surgery
Conference Coverage
Trilogy TAVR safe, effective in aortic regurgitation
One-year mortality rate of 7.8% reported.
From the Journals
Durable LVAD for advanced HF still underutilized
“Many cardiologists are not aware of the amazing survival improvement with modern LVAD technology, and patients are under-referred.”
From the Journals
New tool to guide transcatheter aortic valve replacement
The study demonstrated the “notable feasibility and safety” of TJ-ICE–guided TAVR, the authors write.
Conference Coverage
Hopeful insights, no overall HFpEF gains from splanchnic nerve ablation: REBALANCE-HF
The trial’s potential-responder cohort “seemed able to augment cardiac output in response to stress” and to “maintain or augment their orthostatic...
Conference Coverage
Optimal antiplatelet regimen in ‘bi-risk’ ACS?
OPT-BIRISK tested an antiplatelet strategy “in challenging patients at increased risk for bleeding and ischemic events, but I don’t think we can...
From the Journals
History of heart transplant tied to worse pregnancy outcome
The findings demonstrate the importance of counseling HT patients at early gestational ages “to provide information about anticipated risks in...
From the Journals
More data support heart donation after circulatory death
“These results provide confidence that DCD can be safely and effectively performed without compromising outcomes, at least in a large-volume...
Latest News
Second pig-heart transplant patient at UM faring well
“We’re taking one day at a time. His immune system is still intact, despite the heavy immune suppression.”
Conference Coverage
STEMI trial fails to support post-PCI anticoagulation
“What went wrong? Was it the drugs, the trial, or both?”
Conference Coverage
Should intravascular imaging be almost routine in PCI?
“The challenge, though, will be convincing the average interventional cardiologist worldwide that it was specifically the imaging and not the...
Commentary
Is complete revascularization now compulsory? MULTISTARS-AMI and FIRE in context
We now have more data to support a complete revascularization strategy and even extending that to non-STEMI patients.